Guardian Pharmacy Services, Inc.
$41.83
The Read: 7% dip after solid Q4 2025 results and raised 2026 EBITDA guidance but then rallied sharply, while its Q1 2026 beat and raised guidance triggered only a muted 2.
Price
Overlays
Panel
GRDN
Hover to view data
No Data